• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment

    2020-06-08 05:23:28LiWeiQiuYiFeiLiuXiaoQingCaoYanWangXiaoHongCuiXianYeShuoWenHuangHongJunXieHaiJianZhang
    World Journal of Gastroenterology 2020年18期

    Li-Wei Qiu, Yi-Fei Liu, Xiao-Qing Cao, Yan Wang, Xiao-Hong Cui, Xian Ye, Shuo-Wen Huang, Hong-Jun Xie,Hai-Jian Zhang

    Abstract Hepatocellular carcinoma (HCC) is the most common primary liver cancer with a dismal prognosis, especially when diagnosed at advanced stages. Annexin A2(ANXA2), is found to promote cancer progression and therapeutic resistance.However, the underlining mechanisms of ANXA2 in immune escape of HCC remain poorly understood up to now. Herein, we summarized the molecular function of ANXA2 in HCC and its relationship with prognosis. Furthermore, we tentatively elucidated the underlying mechanism of ANXA2 immune escape of HCC by upregulating the proportion of regulatory T cells and the expression of several inhibitory molecules, and by downregulating the proportion of natural killer cells and dendritic cells and the expression of several inhibitory molecules or effector molecules. We expect a lot of in-depth studies to further reveal the underlying mechanism of ANXA2 in immune escape of HCC in the future.

    Key words: Annexin A2; Hepatocellular carcinoma; Immune microenvironment; Overall survival; Chemotherapy resistance; Checkpoint

    INTRODUCTION

    As an aggressive malignancy, liver cancer is the fifth leading cause of death from cancer globally[1]. Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, has a poor prognosis, especially when diagnosed at the advanced stages[2]. One of the leading risk factors for HCC is infection with the hepatitis B virus,particularly in East Asia[3]. Although surgical treatment for HCC may be effective in the early stages, the 5-year overall survival (OS) rate is only 50%-70%[4,5]. According to a recent study based on proteomic and phosphoproteomic profiling, early-stage HCC can be further stratified into three subtypes with different clinical outcomes[6]. The third subtype, which is characterized by disrupted cholesterol homeostasis, is associated with the lowest postoperative OS rate and the greatest risk of a poor prognosis[7,8]. Despite global advancement of social development and implementation of the annual physical examination program to increase the diagnosis of patients with early-stage HCC, the proportion of patients with advanced HCC at first diagnosis remains high[9]. Although first-line drugs such as sorafenib and lovatinib were used in the treatment of advanced HCC, the landscape of advanced HCC management was not optimistic until the advent of immunotherapy and the knowledge gained about the molecular pathogenesis of the disease[2,10,11].

    HCC is considered to be an immunogenic tumor resulting from diseases that lead to chronic inflammation of the liver[12]. Therefore, immunotherapeutic strategies may represent a key treatment direction for improving the clinical outcomes of patients with HCC[13,14]. In recent years, immune checkpoint inhibitors have emerged as potential drugs with promising therapeutic effects against advanced HCC[15-17];examples include nivolumab[18-20]or pembrolizumab[21,22]for programmed cell death protein 1 (PD-1) blockade, atezolizumab (MPDL3280A) for programmed cell deathligand 1 blockade[23,24], and ipilimumab for cytotoxic T-lymphocyte-associated protein 4 blockade[25]. Of course, the combination of different immunotherapies or of immunotherapies with conventional therapeutic approaches may provide synergistic effects and facilitate the development of personalized medicine[16,26]. However, the molecular mechanisms underlying HCC immune escape remain poorly understood[27-29].

    Annexin A2 (ANXA2, also termed annexin II, p36, calpactin 1 heavy chain, or lipocortin II) was originally extracted from human placenta as an inhibitor of phospholipase A2[30]. The humanANXA2gene, which is located on chromosome 15q21, is 40 kb in length and has 13 exons. It can be cleaved by chymotrypsin into a 3 kDa amino-terminal domain and a 33 kDa carboxyl-terminal domain. The ANXA2 protein can exist as a monomer, heterodimer, or heterotetramerin vivo. The heterodimeric form consists of one subunit of ANXA2 in complex with a molecule of 3-phosphoglycerate kinase, whereas the heterotetrameric form consists of two ANXA2 subunits combined with an S100A10dimer[31].

    The function of ANXA2 is closely related to the form in which it exists. It has been shown that the ANXA2 monomer is localized mainly in the cytoplasm but may transition to the intracellular membrane in response to signals such as changes in the Ca2+concentration, pH, or membrane phospholipid composition. However, the specific biological roles it plays in the subsequent processes are still unclear[32]. The ANXA2 dimer is involved in the formation of intracellular vesicles through combination with multiple endosomes and mediation of membrane fusion[33].Additionally, the dimer is required for the biogenesis of multivesicular bodies as well as being a constituent of exosomes that are frequently cited in proteomic studies[34].The ANXA2 heterotetramers are the most well studied of the three forms, and it is now well established that they serve as an assembly site for plasminogen and tissue plasminogen activator on the endothelial cell surface, thereby promoting the generation of plasmin and allowing the clearance of fibrin formed on the blood vessel surface in response to more subtle forms of vascular injury[35,36].

    In recent years, increasingly more studies have focused on the relationship between ANXA2 and immune-related diseases, such as lupus nephritis, rheumatoid arthritis,and cancer[37-39]. ANXA2 was found to promote various processes related to cancer progression, such as cancer proliferation, migration, epithelial-mesenchymal transition (EMT), invasion, and stem cell formation, as well as their resistance to radiotherapy, chemotherapy, and immunotherapy[40]. There is growing evidence that ANXA2 plays an important role in tumor immune escape[41].

    LITERATURE SEARCH

    A scientific literature search was conducted using the PubMed, Web of Science, and Google Scholar databases. The keywords used included “cancer,” “hepatocellular carcinoma,” “ANXA2,” “immune escape,” “immunotherapy,” “overall survival,” and combinations of the aforementioned terms.

    MOLECULAR FUNCTIONS OF ANXA2 IN CANCER

    Upregulation of ANXA2

    A high level of ANXA2 is characteristic of malignant salivary gland tumors[42]and pulmonary invasive mucinous adenocarcinoma[43]and is associated with DNA repair as well as metabolic alteration in pancreatic ductal adenocarcinoma[44]. ANXA2 is highly expressed in gastric cancer tissues and is related to the tumor size, histological differentiation, tumor-node-metastasis stage, and lymph node metastasis[45]. The ANXA2-S100A10 heterotetramers are upregulated by the promyelocytic leukemia-retinoic acid receptor alpha fusion protein and promotes plasminogendependent fibrinolysis and matrix invasion in acute promyelocytic leukemia[46].ANXA2 overexpression contributes to the aggressive phenotype of triple-negative breast cancer in the African American population[47]. The ANXA2 protein content harbored by extracellular vesicles represents a promising prognostic biomarker in endometrial cancer[48]. The ginsenoside compound K inhibits nuclear factor-kappa B by targeting ANXA2[49,50].

    In a rat model of cirrhosis, after 30 wk of thioacetamide induction, the level of ANXA2 in the liver increased three times over the level before modeling with the dynamic increasing trend being positively correlated with immune factors, such as interleukin and transforming growth factor-beta, indicating the close relationship between ANXA2 and precancerous lesions of HCC[51]. Our previous study results suggested that the circulating levels of ANXA2 in patients with HCC were significantly higher than those in patients with other liver diseases[52]. ANXA2 was frequently found to be upregulated in HCC tissues compared with its levels in benign liver disease tissues and was significantly correlated with the degree of histological differentiation, intrahepatic metastasis, portal vein thrombosis, and tumor-node-metastasis stage[53]. From our present search of The Cancer Genome Atlas database, we have further confirmed that ANXA2 is upregulated in HCC tissues compared with its level in normal tissues (Figure 1A,P< 0.001). In addition,ANXA2is a critical differentially expressed gene in nonalcoholic fatty liver disease, where it is associated with the disease severity and modifiable lifestyle factors[54].

    Signaling pathways

    Figure 1 lnvolvement of Annexin A2 in the change of immune microenvironment. A: The expression of ANXA2 mRNA according to The Cancer Genome Atlas database; B: Increased ANXA2 results in poorer 5-year overall survival; C: The proportion of 22 infiltrating immune cells; D: Gene ontology analysis of differentially expressed genes. ANXA2: Annexin A2; HCC: Hepatocellular carcinoma.

    The interaction of human epididymis protein 4 with ANXA2 promotes the migration of various malignant cells[55]. ANXA2 enhances the progression of colorectal cancer and HCCviastructural rearrangement of the cytoskeleton[56]. The protein also promotes glioma cell proliferation through the signal transducer and activator of transcription 3-cyclin D1 pathway[57]. ANXA2 has been shown to be a specific target of bleomycin, where its binding with the drug impeded the induction of pulmonary fibrosis mediated by the transcription factor EB-induced autophagic flux[58]. The miR155HG-miR-185-ANXA2 loop contributes to glioblastoma progression[59].The long noncoding (lnc) RNA lung cancer-associated transcript 1 promotes tumorigenesis by inhibiting ANXA2 phosphorylation in HCC[60]. The miR-23b-3p-ANXA2 axis inhibits the development and progression of pancreatic ductal adenocarcinoma[61]. ANXA2 was found to promote cancer progression and therapeutic resistance in nasopharyngeal carcinoma[40]. The lncRNA cytoskeleton regulator RNA induces the upregulation of ANXA2 by binding competitively to miR-613, leading to nasopharyngeal carcinoma metastasis[62]. Another lncRNA, colon cancer-associated transcript 1, interacts with ANXA2 to promote beta-catenin translocation to the nucleus where it then activates T-cell factor 4, leading to breast cancer progression[63,64]. The lncRNA small nucleolar RNA host gene 14 potentiates pancreatic cancer progressionviaANXA2 expression upregulation by acting as a competing endogenous RNA for miR-613[65]. Our previous results have suggested that ANXA2 silencing inhibits the invasion, migration, and tumorigenic potential of hepatoma cells[66].

    Epithelial-mesenchymal transition

    ANXA2 overexpression is associated with colorectal cancer invasiveness and TGF?induced EMT through the Src-ANXA2-signal transducer and activator of transcription 3 axis[67]. Mesenchymal stem cells promote hepatocarcinogenesisviathe interaction of ANXA2 with a novel lncRNA termed mesenchymal stem cell-upregulated factor[68].ANXA2 inhibition suppresses ovarian cancer progression through the control of betacatenin and hence EMT[69]. ANXA2 silencing inhibits the proliferation, invasion, and migration of gastric cancer cells[70]as well as non-small cell lung cancer proliferation and EMT through a p53-dependent pathway[71].

    Posttranslational modification

    The phosphorylation of ANXA2 at its tyrosine residue promotes the invasion and metastasis of drug-resistant breast cancer cells[72]. Highly expressed phosphorylated ANXA2 (Tyr23) also promotes esophageal cancer progression by activating the MYChypoxia-inducible factor 1 alpha-vascular endothelial growth factor axis[73]. The tumor suppressor sirtuin 6, which is ubiquitylated and degraded by E3 ubiquitin ligase,contributes to liver tumorigenesis in an ANXA2-dependent manner[74]. Tripartite motif-containing, a novel marker of poor prognosis in ovarian cancer, promotes the malignant progression of the disease by inducing ANXA2 expression[75]. Likewise,tripartite motif-containing 65 supports the aggressiveness of bladder urothelial carcinoma cells by promoting ANXA2 ubiquitination and degradation[76].

    ASSOCIATION OF ANXA2 WITH POOR PROGNOSIS

    Reduced overall survival

    ANXA2 is an independent prognostic biomarker for the malignant progression of laryngeal cancer[77]. The protein may also be a potential prognostic biomarker of liver cancer[78]. The high expression level of ANXA2 in stromal tissue is associated with a reduced OS rate in patients with epithelial ovarian cancer[79], and when highly expressed in cancer cell membranes is associated with poor prognosis in pancreatic cancer[80]. ANXA2 overexpression is predictive of decreased survival in patients with pancreatic cancer[81]and triple-negative breast cancer[82]. According to a quantitative phosphoproteomic analysis, the phosphorylation of ANXA2 Tyr23 is associated with poor prognosis in HCC[83]. Our previous research results confirmed that an increased level of ANXA2 was closely associated with a shortened OS rate in patients with HCC and was therefore identified as an independent prognostic factor of this disease[53].Herein, working with data from the Cancer Genome Atlas database, we further confirmed that patients with HCC with high ANXA2 expression levels had a shorter OS (Figure 1B,P< 0.001).

    Drug resistance

    A combinedANXA2-N-Myc downstream regulated 1-signal transducer and activator of transcription 1gene signature predicts the response of patients with cervical cancer to chemoradiotherapy[84]. The interaction of P37 with ANXA2 is required for the mycoplasma-associated multidrug resistance of hepatocarcinoma cells[85]. ANXA2 contributes to cisplatin resistance in cells of non-small cell lung cancer by activating the c-Jun N-terminal kinase-p53 pathway[86]and enhances multidrug resistance in pediatric neuroblastoma by regulating the nuclear factor-kappa B signaling pathway[87]. MiR-101 alleviates the chemoresistance of gastric cancer cells by targeting ANXA2[88]. Chemotherapy combined with bevacizumab can effectively destroy advanced lung adenocarcinoma cells harboringepidermal growth factor receptor-ANXA2mutations[89].

    ROLE OF ANXA2 IN THE CHAOTIC IMMUNE MICROENVIRONMENT

    A study of the antitumor effect of a vaccine prepared from H22 hepatocarcinoma cells induced by cartilage polysaccharides found ANXA2 to be closely related to oncogenesis and cancer development, invasion, and metastasis. A major increase in ANXA2 mRNA was found in the cartilage polysaccharide-induced H22 cells. The data suggested that ANXA2, a specific antigen, may play a key role in the antitumor immune response of HCC and in activating the immune system[90]. ANXA2 was found to be a tumor-associated antigen in patients with lung cancer who had been exposed to asbestos[91]. It has also been implicated in the attachment and entry, genome replication and expression, assembly, and egress of viruses[92].

    ANXA2 is essential for the trafficking and capsid disassembly of oncogenic human papillomavirus and protects the virions from lysosomal degradation[93]. The cellsurface translocation of ANXA2 contributes to bleomycin-induced pulmonary fibrosis through its mediation of the inflammatory response in mice[94]. Stromal cell-derived factor-1 alpha triggers theengulfment and cell motility 1gene-dependent membrane translocation of ANXA2 for the regulation of HCC chemotaxis and metastasis[95].

    Cancer-associated fibroblasts promote EMT and epidermal growth factor receptor-tyrosine kinase inhibitor resistance in non-small cell lung cancersviahepatocyte growth factor-insulin-like growth factor-1-ANXA2 signaling[96]. A study on the pathogenesis of immune-mediated liver fibrosis found that after modeling of the disease in rats by injection with pig serum, the ANXA2 concentration increased continually in the rat liver during the process of fibrosis. Similarly, the serum levels of ANXA2 in patients with liver fibrosis were upregulated by 1.4-fold compared with the levels in healthy individuals. When Huh7 cells were exposed to the hepatitis B virusin vitro, ANXA2 translocated from the nucleus and cytoplasm to the cytoplasmic membrane, which suggested that it was involved in the immune-mediated liver injury caused by the virus[97]. Dendritic cells (DCs) respond to nasopharyngeal carcinoma cells through an ANXA2-recognizing C-type lectin, named DC-specific intercellular adhesion molecule 3-grabbing nonintegrin[98].

    In this present review, our analysis of Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts data[99]revealed that elevated ANXA2 levels resulted in a higher proportion of Treg cells (P< 0.001) and lower proportions of activated natural killer (NK) cells (P= 0.046) and DCs (P= 0.032) than those found in the low-ANXA2 group and in some nonfunctional immune cells (Figure 1C).Furthermore, our Gene Ontology analysis of differentially expressed genes (false discovery rate < 0.05; fold change = 2) suggested that signatures of functional regulation in Treg, NK, and DC cells were enriched (Figure 1D) in patients with HCC.

    In addition, ANXA2 plays a key role in nontumorous immunological diseases.Soluble ANXA2 activates human macrophagesviamitogen-activated protein kinases and may be capable of acting as an inflammatory mediator[100]. ANXA2 expression was downregulated in myeloid cells that had been induced to differentiate through stimulation with all-trans retinoic acid[101]. An immune response mediated by ANXA2 autoantibodies resulted in high circulating levels of interleukin-6 in serum samples from patients with lung cancer[102].

    ROLE OF ANXA2 IN IMMUNE ESCAPE

    A recent study has shown that T-cell activation, proliferation, and cluster formation are dependent on the proteases tissue plasminogen activator and plasmin[103]. The tissue plasminogen activator treatment of T cells increased the cleavage of ANXA2,which regulates the actin cytoskeleton. Live cell imaging of the activated T cells further indicated a negative role of the ANXA2-regulated actin cytoskeleton in T-cell clustering. This may be one of the mechanisms by which the upregulation of ANXA2 in tumors leads to decreased T-cell activation and an imbalance of the tumor microenvironment[103].The soluble ANXA2 released by tumor cells has novel immunosuppressive properties in patients with renal cell carcinoma[104]. Elevated serum levels of ANXA2 may be important for the suppression of the immune response[105]. AListeria-based ANXA2-targeting immunotherapy in combination with anti-PD-1 antibodies demonstrated high efficacy against pancreatic tumors[39]. ANXA2 in the cancerous cell membrane was identified as the direct antigenic ligand of the Vγ8Vδ3 T-cell receptor of γδ T cells, which make up the first line of defense of stressed cells[41].

    At present, there are limited published studies on the role of ANXA2 in immune escape. In this review, we analyzed the correlations of partially labeled genes of Treg cells (Figure 2A), activated NK cells (Figure 2B), and DCs (Figure 2C). We further confirmed that an elevated ANXA2 level results in the upregulation of several checkpoint molecules, such as PD-1, hepatitis A virus cellular receptor 2, gelectin-9,cytotoxic T-lymphocyte-associated protein 4, CD86, and CD80 (Figure 2D). Moreover,we also found that elevated ANXA2 levels result in the downregulation of several inhibitory molecules (e.g., TGFβ and interleukin-10), and effector molecules (e.g.,perforin 1, granzyme B, interferon-gamma, and tumor necrosis factor-alpha; Figure 2E). These results suggest that elevated ANXA2 levels contribute to HCC immune escape.

    CONCLUSION

    ANXA2 is usually overexpressed in cancerous tissue and results in shorter OS and chemotherapy resistance in patients with HCC[106]. Furthermore, an elevated ANXA2 level results in the upregulation of both the proportion of Treg cells and the expression of several checkpoint molecules as well as the downregulation of both the proportions of activated NK cells and DCs and of several inhibitory molecules.Although there are few research studies to date on the role of ANXA2 in tumor immune escape, we expect a future increase in the number of in-depth studies being carried out to reveal the mechanism through which ANXA2 mediates the immune escape of HCC.

    Figure 2 lncreased Annexin A2 promotes immune escape in hepatocellular carcinoma patients. A: Correlation of partial labeled genes of regulatory T cells; B:Correlation of partial labeled genes of activated natural killer cells; C: Correlation of partial labeled genes of activated dendritic cells; D: The expression of partial checkpoint molecules; E: The expression of partial inhibitory molecules and effector molecules. ANXA2: Annexin A2; NK: Natural killer.

    男男h啪啪无遮挡| 久久99一区二区三区| 中亚洲国语对白在线视频| 国产欧美日韩一区二区精品| 免费在线观看日本一区| 亚洲欧美日韩另类电影网站| 日韩视频在线欧美| 亚洲精品美女久久av网站| 这个男人来自地球电影免费观看| 国产精品 欧美亚洲| 亚洲av成人一区二区三| 亚洲av成人不卡在线观看播放网| 一个人免费在线观看的高清视频| 亚洲成a人片在线一区二区| 久久 成人 亚洲| 亚洲五月色婷婷综合| 亚洲国产看品久久| 亚洲欧美一区二区三区黑人| 欧美中文综合在线视频| 亚洲欧美日韩另类电影网站| 亚洲视频免费观看视频| 欧美精品一区二区免费开放| bbb黄色大片| 免费av中文字幕在线| 欧美大码av| 久久九九热精品免费| 亚洲精华国产精华精| 首页视频小说图片口味搜索| xxxhd国产人妻xxx| 亚洲欧美激情在线| 国产精品1区2区在线观看. | 国产精品美女特级片免费视频播放器 | 日本黄色日本黄色录像| 日本黄色日本黄色录像| 欧美日韩亚洲综合一区二区三区_| 国产精品偷伦视频观看了| 三级毛片av免费| 美女扒开内裤让男人捅视频| 夫妻午夜视频| 午夜免费鲁丝| 91九色精品人成在线观看| 黄色视频在线播放观看不卡| 悠悠久久av| 亚洲美女黄片视频| 午夜福利乱码中文字幕| 99re6热这里在线精品视频| 久久中文字幕一级| 99精国产麻豆久久婷婷| 在线观看免费日韩欧美大片| 99久久国产精品久久久| 在线av久久热| 美女扒开内裤让男人捅视频| 中文字幕av电影在线播放| 两性午夜刺激爽爽歪歪视频在线观看 | 91字幕亚洲| av在线播放免费不卡| 亚洲精品中文字幕一二三四区 | 国产不卡av网站在线观看| 欧美在线一区亚洲| 精品第一国产精品| 亚洲欧美激情在线| 成人免费观看视频高清| 可以免费在线观看a视频的电影网站| 又黄又粗又硬又大视频| 波多野结衣av一区二区av| 91av网站免费观看| 夫妻午夜视频| 老汉色∧v一级毛片| 日本黄色日本黄色录像| 首页视频小说图片口味搜索| 美女国产高潮福利片在线看| a级片在线免费高清观看视频| 免费看十八禁软件| 脱女人内裤的视频| 黑人巨大精品欧美一区二区蜜桃| 大陆偷拍与自拍| 三级毛片av免费| 99九九在线精品视频| 精品亚洲乱码少妇综合久久| 交换朋友夫妻互换小说| 亚洲情色 制服丝袜| 精品国产亚洲在线| 人人妻人人澡人人爽人人夜夜| 亚洲国产av新网站| 我要看黄色一级片免费的| 国产野战对白在线观看| 在线天堂中文资源库| 美女高潮到喷水免费观看| 亚洲七黄色美女视频| 国产在线免费精品| 视频在线观看一区二区三区| 精品久久久久久电影网| 熟女少妇亚洲综合色aaa.| 亚洲精品国产色婷婷电影| 日日摸夜夜添夜夜添小说| 热re99久久国产66热| 亚洲欧美一区二区三区久久| 午夜激情av网站| 在线亚洲精品国产二区图片欧美| 久久久久久人人人人人| 久久久久网色| 在线 av 中文字幕| 欧美日韩国产mv在线观看视频| 欧美激情久久久久久爽电影 | 亚洲精品久久成人aⅴ小说| 亚洲熟妇熟女久久| 免费观看人在逋| 如日韩欧美国产精品一区二区三区| 成人国产av品久久久| 蜜桃国产av成人99| 日本欧美视频一区| 亚洲精品美女久久av网站| 久久99一区二区三区| 国产麻豆69| av天堂久久9| 一边摸一边抽搐一进一出视频| 99re在线观看精品视频| 超色免费av| 窝窝影院91人妻| av天堂在线播放| 国内毛片毛片毛片毛片毛片| 法律面前人人平等表现在哪些方面| 精品少妇一区二区三区视频日本电影| 女性生殖器流出的白浆| 一本色道久久久久久精品综合| 亚洲一区中文字幕在线| 99在线人妻在线中文字幕 | 午夜91福利影院| 亚洲欧美色中文字幕在线| 啪啪无遮挡十八禁网站| 最新美女视频免费是黄的| 超碰97精品在线观看| 大香蕉久久网| 一区二区av电影网| 欧美人与性动交α欧美软件| 另类亚洲欧美激情| 人人妻人人澡人人看| 性少妇av在线| 曰老女人黄片| 国产精品二区激情视频| 成人国语在线视频| 少妇 在线观看| 国产一区二区三区综合在线观看| 欧美一级毛片孕妇| 欧美日韩亚洲高清精品| 男女免费视频国产| 脱女人内裤的视频| 日韩成人在线观看一区二区三区| 日韩大码丰满熟妇| 丰满少妇做爰视频| 国产精品免费一区二区三区在线 | 最新在线观看一区二区三区| 麻豆乱淫一区二区| 亚洲性夜色夜夜综合| 国产激情久久老熟女| 日韩中文字幕欧美一区二区| 人人妻人人澡人人爽人人夜夜| 精品午夜福利视频在线观看一区 | 狠狠婷婷综合久久久久久88av| 国产精品免费大片| 妹子高潮喷水视频| 国产亚洲精品久久久久5区| 高清在线国产一区| 狠狠精品人妻久久久久久综合| 99国产综合亚洲精品| 亚洲综合色网址| 午夜两性在线视频| 精品久久久久久久毛片微露脸| 午夜激情久久久久久久| 美女视频免费永久观看网站| 亚洲av欧美aⅴ国产| 黄片播放在线免费| 亚洲第一av免费看| 又大又爽又粗| 香蕉久久夜色| 啦啦啦免费观看视频1| 中亚洲国语对白在线视频| 窝窝影院91人妻| 亚洲欧美色中文字幕在线| 超色免费av| 日日夜夜操网爽| 国产在线观看jvid| 午夜精品久久久久久毛片777| 91九色精品人成在线观看| 两个人免费观看高清视频| 麻豆国产av国片精品| 我要看黄色一级片免费的| 国产精品免费一区二区三区在线 | 一级毛片电影观看| 极品少妇高潮喷水抽搐| 亚洲色图 男人天堂 中文字幕| 精品国产国语对白av| 国产主播在线观看一区二区| 亚洲人成伊人成综合网2020| 一二三四在线观看免费中文在| 五月开心婷婷网| 亚洲综合色网址| 丝袜在线中文字幕| 亚洲国产欧美一区二区综合| 国产在视频线精品| 亚洲精品国产精品久久久不卡| 老司机午夜福利在线观看视频 | 精品国产乱码久久久久久男人| 久久久精品94久久精品| 国产欧美日韩一区二区三区在线| 久久亚洲真实| 亚洲色图综合在线观看| 久久av网站| 亚洲国产av新网站| 国产精品久久久久久精品古装| 中文字幕另类日韩欧美亚洲嫩草| 国产99久久九九免费精品| 亚洲国产毛片av蜜桃av| 一区二区av电影网| 日本黄色视频三级网站网址 | 国产97色在线日韩免费| 动漫黄色视频在线观看| 久久久久久久久久久久大奶| 久久精品亚洲精品国产色婷小说| 国产在线免费精品| 久久热在线av| 国产日韩欧美在线精品| 亚洲国产av影院在线观看| 黄色成人免费大全| 久久人妻熟女aⅴ| 精品第一国产精品| 人妻 亚洲 视频| 日本一区二区免费在线视频| 激情视频va一区二区三区| 久久中文字幕人妻熟女| 亚洲 欧美一区二区三区| 日韩 欧美 亚洲 中文字幕| 制服诱惑二区| 少妇 在线观看| 精品国产一区二区三区久久久樱花| 国产日韩一区二区三区精品不卡| 亚洲精品久久成人aⅴ小说| 无人区码免费观看不卡 | 精品国产一区二区久久| 精品一区二区三区视频在线观看免费 | 老司机在亚洲福利影院| 少妇裸体淫交视频免费看高清 | 亚洲一卡2卡3卡4卡5卡精品中文| a级毛片黄视频| 性高湖久久久久久久久免费观看| 黄片播放在线免费| 久久久欧美国产精品| 国产一区二区在线观看av| 黄网站色视频无遮挡免费观看| 国内毛片毛片毛片毛片毛片| 精品高清国产在线一区| 国产一卡二卡三卡精品| 夫妻午夜视频| 精品国产一区二区三区四区第35| av片东京热男人的天堂| 嫩草影视91久久| 大香蕉久久成人网| 麻豆成人av在线观看| 免费观看人在逋| 窝窝影院91人妻| 国产精品久久久人人做人人爽| 菩萨蛮人人尽说江南好唐韦庄| 欧美成人午夜精品| 国产精品久久久久久人妻精品电影 | 欧美老熟妇乱子伦牲交| 国产激情久久老熟女| 国产男靠女视频免费网站| 欧美精品一区二区免费开放| 日韩一区二区三区影片| 久久久久久久久久久久大奶| 女性被躁到高潮视频| 亚洲中文av在线| 丰满迷人的少妇在线观看| 午夜福利欧美成人| 少妇的丰满在线观看| 好男人电影高清在线观看| 最新的欧美精品一区二区| 欧美人与性动交α欧美软件| 亚洲九九香蕉| 亚洲中文日韩欧美视频| 国产亚洲欧美在线一区二区| 我的亚洲天堂| 午夜福利,免费看| 熟女少妇亚洲综合色aaa.| 男女午夜视频在线观看| 老司机午夜十八禁免费视频| 伊人久久大香线蕉亚洲五| 欧美日韩成人在线一区二区| 久热爱精品视频在线9| 51午夜福利影视在线观看| 真人做人爱边吃奶动态| 日本黄色日本黄色录像| 精品一区二区三区av网在线观看 | 大码成人一级视频| 少妇精品久久久久久久| 99热国产这里只有精品6| 欧美成人午夜精品| 欧美精品一区二区大全| 免费日韩欧美在线观看| 狠狠狠狠99中文字幕| 亚洲av片天天在线观看| 人人妻人人澡人人爽人人夜夜| 91老司机精品| 免费在线观看完整版高清| 国产精品免费大片| 在线观看免费视频网站a站| 亚洲成国产人片在线观看| 黑人巨大精品欧美一区二区蜜桃| 国产成人一区二区三区免费视频网站| 亚洲专区中文字幕在线| 中文字幕人妻熟女乱码| 成人av一区二区三区在线看| 麻豆国产av国片精品| 亚洲成人免费电影在线观看| 免费人妻精品一区二区三区视频| 国产精品亚洲一级av第二区| 国产成人影院久久av| 下体分泌物呈黄色| 亚洲国产欧美一区二区综合| 亚洲欧美精品综合一区二区三区| 一级片免费观看大全| 岛国在线观看网站| 久久中文字幕人妻熟女| 无限看片的www在线观看| 亚洲av电影在线进入| 国精品久久久久久国模美| 国产伦理片在线播放av一区| 精品第一国产精品| 亚洲久久久国产精品| 久久午夜综合久久蜜桃| 亚洲精品久久成人aⅴ小说| 精品久久蜜臀av无| 国产又爽黄色视频| 777米奇影视久久| 亚洲成人免费av在线播放| bbb黄色大片| 免费在线观看影片大全网站| 久久久国产成人免费| 日韩中文字幕欧美一区二区| 欧美乱妇无乱码| av在线播放免费不卡| 桃花免费在线播放| tube8黄色片| av片东京热男人的天堂| tube8黄色片| e午夜精品久久久久久久| 日韩制服丝袜自拍偷拍| 视频区图区小说| 999久久久国产精品视频| 美女主播在线视频| 伊人久久大香线蕉亚洲五| 欧美日韩福利视频一区二区| 男人舔女人的私密视频| 黄色片一级片一级黄色片| 久久久久久久大尺度免费视频| 久久性视频一级片| 老司机靠b影院| 欧美精品一区二区免费开放| 成人av一区二区三区在线看| 视频区图区小说| 亚洲专区中文字幕在线| 日韩一卡2卡3卡4卡2021年| av线在线观看网站| 两人在一起打扑克的视频| 精品人妻1区二区| 亚洲国产av影院在线观看| 99久久人妻综合| 黄色片一级片一级黄色片| 好男人电影高清在线观看| 国产成人av教育| 大型黄色视频在线免费观看| 日本vs欧美在线观看视频| 日韩制服丝袜自拍偷拍| 十分钟在线观看高清视频www| 在线观看人妻少妇| 少妇的丰满在线观看| 丁香欧美五月| 法律面前人人平等表现在哪些方面| avwww免费| 国产精品免费大片| 1024香蕉在线观看| 黄色怎么调成土黄色| 欧美日本中文国产一区发布| 一级毛片精品| 久久国产精品大桥未久av| 在线观看舔阴道视频| 国产精品自产拍在线观看55亚洲 | 精品亚洲成a人片在线观看| 国产区一区二久久| 国产一区有黄有色的免费视频| 在线av久久热| 亚洲精品久久成人aⅴ小说| 黑人猛操日本美女一级片| 他把我摸到了高潮在线观看 | 女性生殖器流出的白浆| 一区二区三区乱码不卡18| 久久人妻福利社区极品人妻图片| 两性午夜刺激爽爽歪歪视频在线观看 | 天天影视国产精品| 国产成人啪精品午夜网站| 国产av一区二区精品久久| 色尼玛亚洲综合影院| 国产欧美日韩一区二区三| 亚洲欧洲精品一区二区精品久久久| 亚洲第一青青草原| 日日摸夜夜添夜夜添小说| 久久精品人人爽人人爽视色| 我要看黄色一级片免费的| 最近最新中文字幕大全免费视频| 国产精品98久久久久久宅男小说| 两性夫妻黄色片| 999精品在线视频| 美女主播在线视频| videos熟女内射| 久久精品国产99精品国产亚洲性色 | 狠狠狠狠99中文字幕| 手机成人av网站| av超薄肉色丝袜交足视频| 国产精品亚洲一级av第二区| 中文字幕人妻熟女乱码| 丁香六月天网| 国产亚洲午夜精品一区二区久久| 1024香蕉在线观看| 啦啦啦视频在线资源免费观看| 久久精品人人爽人人爽视色| 99国产精品一区二区三区| 老鸭窝网址在线观看| 久久国产精品影院| 久久久国产成人免费| 韩国精品一区二区三区| 久久精品国产99精品国产亚洲性色 | 母亲3免费完整高清在线观看| 在线观看免费视频日本深夜| 99精品久久久久人妻精品| 欧美日韩黄片免| 亚洲av国产av综合av卡| 亚洲午夜精品一区,二区,三区| 757午夜福利合集在线观看| 午夜视频精品福利| 又大又爽又粗| 亚洲自偷自拍图片 自拍| 视频区欧美日本亚洲| 免费在线观看完整版高清| 男女下面插进去视频免费观看| 日日夜夜操网爽| 免费少妇av软件| 国产麻豆69| 在线观看www视频免费| 狠狠狠狠99中文字幕| 50天的宝宝边吃奶边哭怎么回事| 免费黄频网站在线观看国产| 日韩有码中文字幕| 一区二区三区激情视频| 一夜夜www| 高潮久久久久久久久久久不卡| 久久狼人影院| 亚洲国产av影院在线观看| 欧美日韩亚洲高清精品| 亚洲黑人精品在线| 人人妻人人爽人人添夜夜欢视频| 精品少妇内射三级| 久久人妻福利社区极品人妻图片| 一级a爱视频在线免费观看| 中文欧美无线码| 黑人巨大精品欧美一区二区蜜桃| 欧美日韩亚洲国产一区二区在线观看 | 国产精品久久久久成人av| 亚洲av欧美aⅴ国产| 在线观看www视频免费| 三级毛片av免费| 国产成人系列免费观看| 亚洲精品国产色婷婷电影| 日韩三级视频一区二区三区| 99国产精品一区二区三区| 这个男人来自地球电影免费观看| 久久人人97超碰香蕉20202| 大码成人一级视频| 亚洲男人天堂网一区| 男男h啪啪无遮挡| 国产伦人伦偷精品视频| 侵犯人妻中文字幕一二三四区| 最黄视频免费看| 波多野结衣av一区二区av| 午夜成年电影在线免费观看| 欧美激情极品国产一区二区三区| 不卡av一区二区三区| 高清毛片免费观看视频网站 | 欧美乱码精品一区二区三区| 男女边摸边吃奶| 少妇粗大呻吟视频| 亚洲成国产人片在线观看| 蜜桃在线观看..| 精品高清国产在线一区| 久久久久久久久久久久大奶| 国产欧美日韩一区二区三区在线| 精品久久蜜臀av无| 99精品欧美一区二区三区四区| 午夜91福利影院| a级毛片在线看网站| 老汉色∧v一级毛片| 久久久久久亚洲精品国产蜜桃av| 国产精品久久久人人做人人爽| 日日摸夜夜添夜夜添小说| 亚洲精品中文字幕一二三四区 | 99热网站在线观看| 亚洲视频免费观看视频| 午夜久久久在线观看| 亚洲男人天堂网一区| 在线观看舔阴道视频| 1024视频免费在线观看| 国产深夜福利视频在线观看| 欧美国产精品一级二级三级| 捣出白浆h1v1| 国产老妇伦熟女老妇高清| 91国产中文字幕| 国产亚洲精品第一综合不卡| 国产人伦9x9x在线观看| 黑丝袜美女国产一区| 一级黄色大片毛片| 久9热在线精品视频| 午夜福利视频在线观看免费| 久久人妻av系列| 国产精品一区二区在线观看99| 午夜激情av网站| 日本一区二区免费在线视频| 国产高清激情床上av| 免费一级毛片在线播放高清视频 | 一边摸一边做爽爽视频免费| 久久这里只有精品19| 国产免费av片在线观看野外av| 在线观看免费高清a一片| 母亲3免费完整高清在线观看| 国产欧美日韩一区二区三区在线| 免费久久久久久久精品成人欧美视频| 岛国毛片在线播放| 午夜激情av网站| 午夜老司机福利片| 国产精品久久久人人做人人爽| 国产成人精品久久二区二区免费| 久久精品成人免费网站| 日韩欧美国产一区二区入口| 在线播放国产精品三级| 国产av精品麻豆| 在线观看免费视频日本深夜| 国产区一区二久久| 99精品欧美一区二区三区四区| 国产精品久久久久成人av| 日本av免费视频播放| 国产又爽黄色视频| 亚洲精品久久午夜乱码| 亚洲一码二码三码区别大吗| 国产欧美日韩一区二区三区在线| 国产精品欧美亚洲77777| 午夜福利免费观看在线| 亚洲精品成人av观看孕妇| 夜夜夜夜夜久久久久| 日韩欧美三级三区| 欧美性长视频在线观看| tocl精华| 欧美在线黄色| 少妇猛男粗大的猛烈进出视频| 色精品久久人妻99蜜桃| 精品亚洲乱码少妇综合久久| 精品第一国产精品| 亚洲欧美一区二区三区黑人| 欧美日韩亚洲高清精品| 国产精品 欧美亚洲| 国产男女超爽视频在线观看| 亚洲中文字幕日韩| 成年女人毛片免费观看观看9 | 天堂中文最新版在线下载| 成人av一区二区三区在线看| 多毛熟女@视频| 黄色视频,在线免费观看| 亚洲精品成人av观看孕妇| 在线av久久热| 亚洲熟妇熟女久久| 黄色成人免费大全| 夜夜夜夜夜久久久久| 99re6热这里在线精品视频| 久久久久网色| 国产麻豆69| 人妻一区二区av| 欧美精品啪啪一区二区三区| 99香蕉大伊视频| 久久毛片免费看一区二区三区| 一本久久精品| 99精品久久久久人妻精品| 国产免费av片在线观看野外av| av电影中文网址| 美女主播在线视频| 国产精品国产av在线观看| 欧美乱码精品一区二区三区| 国产av又大| 国产精品香港三级国产av潘金莲| 亚洲国产欧美网| 日本av免费视频播放| 在线观看免费视频网站a站| 99九九在线精品视频| 久久精品亚洲av国产电影网| 国产一区有黄有色的免费视频| 亚洲精品av麻豆狂野| 亚洲一区二区三区欧美精品| videos熟女内射| 制服人妻中文乱码| 美女高潮到喷水免费观看| 免费日韩欧美在线观看| 在线观看免费午夜福利视频| 在线永久观看黄色视频| 亚洲国产欧美网| 亚洲精华国产精华精| 中文字幕制服av| 欧美日韩亚洲国产一区二区在线观看 | 欧美激情 高清一区二区三区| 老司机亚洲免费影院|